UTMB develops a universal vaccine platform that’s cheaper and shelf stable
Researchers at The University of Texas Medical Branch at Galveston have developed a less expensive way to produce vaccines that cuts the cost of vaccine production and storage by 80 percent without decreasing safety or effectiveness. The findings are currently available in EBioMedicine.
Vaccines are the most effective way to prevent and eradicate infectious diseases. Currently, many vaccines have to be manufactured in cell culture or eggs, which is expensive and carries the risk of contaminations. In addition, most vaccines must be kept refrigerated during the transportation from manufacturers to health care clinics. In tropical and subtropical regions, such cold storage requirements could contribute to more than 80 percent of the vaccine cost.
“The ability to eliminate cell culture or eggs and cold storage will change the process of vaccine development,” said UTMB’s Pei-Yong Shi, professor in the department of biochemistry and molecular biology. “Importantly, this vaccine technology could potentially serve as a universal platform for development of live-attenuated vaccines for many viral pathogens.”
To achieve these goals, the UTMB team engineered a live-attenuated Zika vaccine in the DNA form. Once the DNA is delivered into our body, it launches the vaccine in our cells, leading to antibody production and other protective immunity. With this production method, there is no need to manufacture the vaccine in cell culture or eggs at factories. Because DNA molecules are shelf stable, the vaccine will not expire at warm temperatures and could be stockpiled at room temperature for years.
Using UTMB’s Zika vaccine as a model, the research group showed that the DNA platform worked very efficiently in mice. After a single low dose, the DNA vaccine protected mice from Zika virus infection, mother-to-fetus transmission during pregnancy and male reproductive tract infection and damage.
“This is the first study to demonstrate that, after a single low dose, a DNA vaccine could induce saturated protective immunity,” Shi said. “We will continue testing this promising Zika vaccine platform and then apply the platform to other viruses.”
The Latest on: Vaccine production
via Google News
The Latest on: Vaccine production
- CT Releases Vaccine Age Group Information For First Timeon January 21, 2021 at 6:16 pm
State officials released data about what percentage of age groups have received the coronavirus vaccine to date.
- Health experts blame rapid expansion for vaccine shortageson January 21, 2021 at 6:12 pm
Public health experts are blaming COVID-19 vaccine shortages around the U.S. in part on the Trump administration’s push to get states to vastly expand their vaccination drives to reach the nation’s es ...
- Hoffa: Defense Production Act Critical To Delivering COVID-19 Vaccine To Every Americanon January 21, 2021 at 5:30 pm
The following is a statement from Teamsters General President Jim Hoffa on President Biden's decision to invoke the Defense Production Act (DPA) to address vaccine and PPE shortages. "The Teamsters ...
- Biden signs executive orders on COVID-19 response, authorizes broader use of Defense Production Act to speed vaccineon January 21, 2021 at 5:05 pm
Biden signs executive orders on COVID-19 response, authorizes broader use of Defense Production Act to speed vaccine ...
- Biden hopes Defense Production Act can aid vaccine production; experts say it will take timeon January 21, 2021 at 4:47 pm
On his second day in office President Biden said he would invoke the Defense Production Act to speed up COVID-19 vaccine production. But whether that can rapidly increase output is an open question, ...
- Rate of state’s vaccine distribution could potentially speed up depending on productionon January 21, 2021 at 2:26 pm
The state continues to be one of the best in the nation when it comes to vaccinations and Gov. Ned Lamont announced that the timeline may speed up.
- U.S. vaccine supply: Can Biden boost production?on January 21, 2021 at 1:46 pm
Demand for vaccines is skyrocketing as the United States grapples with a record death toll from COVID-19 and the threat of new, more contagious variants. After a slow start in December, many states ...
- COVID-19 vaccine production unaffected by deadly Indian fire, company sayson January 21, 2021 at 12:07 pm
The Serum Institute of India, the world's biggest vaccine maker, said on Thursday that production of the AstraZeneca coronavirus vaccine would not be affected by a deadly fire at its headquarters in ...
- Five Dead In India Vaccine Plant Fire; Coronavirus Drug Production Unaffectedon January 21, 2021 at 5:39 am
Five people died as a fire tore through a building in the world's biggest vaccine manufacturing hub in India Thursday, but the company insisted that the production of drugs to counter the coronavirus ...
via Bing News